Table 1.
Parameter | Study group CA (n = 16) | Study group CC (n = 15) | ||||
---|---|---|---|---|---|---|
Average | (Range) | SD | Average | (Range) | SD | |
API I | 55.69 | (42–100) | 27.50 | 51.31 | (28.5–83) | 17.44 |
| ||||||
API II | 43.02 | (31–75) | 20.35 | 43.95 | (26–69.5) | 13.56 |
| ||||||
API III | 31.85 | (23–50) | 14.89 | 36.98 | (21.7–65) | 12.36 |
| ||||||
SBI I | 1.32 | 0–0.5 (0%) | 0.60 | 1.21 | 0–0.5 (0%) | 0.70 |
0.5–1.5 (56%) | 0.5–1.5 (73%) | |||||
1.5–2.5 (44%) | 1.5–2.5 (27%) | |||||
| ||||||
SBI II | 1.03 | 0–0.5 (0%) | 0.49 | 1.21 | 0–0.5 (7%) | 0.59 |
0.5–1.5 (75%) | 0.5–1.5 (73%) | |||||
1.5–2.5 (25%) | 1.5–2.5 (20%) | |||||
| ||||||
SBI III | 0.77 | 0–0.5 (19%) | 0.44 | 0.94 | 0–0.5 (13%) | 0.54 |
0.5–1.5 (81%) | 0.5–1.5 (80%) | |||||
1.5–2.5 (0%) | 1.5–2.5 (7%) | |||||
| ||||||
OHI I | 1.45 | 0–0.5 (0%) | 0.61 | 1.26 | 0–0.5 (6.5%) | 0.43 |
0.5–1.5 (69%) | 0.5–1.5 (67%) | |||||
1.5–2.5 (25%) | 1.5–2.5 (20%) | |||||
2.5–3.5 (6%) | 2.5–3.5 (6.5%) | |||||
| ||||||
OHI II | 1.03 | 0–0.5 (0%) 0.5–1.5 (75%) 1.5–2.5 (25%) |
0.44 | 1.02 | 0–0.5 (6.7%) | 0.38 |
0.5–1.5 (80%) | ||||||
1.5–2.5 (6.7%) | ||||||
2.5–3.5 (6.7%) | ||||||
| ||||||
OHI III | 0.70 | 0–0.5 (37.5%) | 0.27 | 0.83 | 0–0.5 (13.2%) | 0.38 |
0.5–1.5 (56%) | 0.5–1.5 (73.5%) | |||||
1.5–2.5 (6.5%) | 1.5–2.5 (13.2%) |
I: first visit, day 1 after the surgery (before CA or CC gel application, baseline).
II: second visit, day 8 after the surgery.
III: third visit, day 22 after the surgery (following CC or CA gel application, final assessment).